GlassScriptPhysician profile
Joshua L Ward
NPI 1912118944
$4,131.01
in general payments reported to CMS, 2019-2025
43 companies · $436 in 2025
The $436 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $265 · 2021: $888 · 2022: $801 · 2023: $719 · 2024: $485 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $560.47 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $464.87 | 2021-2025 | |
| Abbvie INC. | $458.02 | 2019-2024 | Lo Loestrin Fe, Linzess, Viberzi |
| Pfizer INC. | $294.36 | 2022-2024 | |
| Evofem Biosciences, INC. | $236.08 | 2021-2022 | |
| Allergan, INC. | $199.57 | 2019-2021 | |
| Hologic Sales and Service, LLC | $196.35 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Organon LLC | $190.56 | 2021-2025 | Nexplanon |
| Avion Pharmaceuticals | $170.81 | 2020-2022 | |
| Amgen INC. | $168.20 | 2019-2025 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $155.39 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $96.54 | 2023-2024 | Veozah, Myrbetriq |
| Myriad Women'S Health, INC. | $95.42 | 2023 | Myrisk |
| Merck Sharp & Dohme LLC | $75.25 | 2019-2024 | Gardasil, Gardasil 9 |
| Millicent US INC | $53.93 | 2025 | Femlyv, Intrarosa |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.